186 related articles for article (PubMed ID: 20528954)
1. Lack of promoter IV-driven BDNF transcription results in depression-like behavior.
Sakata K; Jin L; Jha S
Genes Brain Behav; 2010 Oct; 9(7):712-21. PubMed ID: 20528954
[TBL] [Abstract][Full Text] [Related]
2. Effects of antidepressant treatment on mice lacking brain-derived neurotrophic factor expression through promoter IV.
Sakata K; Mastin JR; Duke SM; Vail MG; Overacre AE; Dong BE; Jha S
Eur J Neurosci; 2013 Jun; 37(11):1863-74. PubMed ID: 23406189
[TBL] [Abstract][Full Text] [Related]
3. Enriched environment treatment reverses depression-like behavior and restores reduced hippocampal neurogenesis and protein levels of brain-derived neurotrophic factor in mice lacking its expression through promoter IV.
Jha S; Dong B; Sakata K
Transl Psychiatry; 2011 Sep; 1(9):e40. PubMed ID: 22832656
[TBL] [Abstract][Full Text] [Related]
4. Lack of BDNF expression through promoter IV disturbs expression of monoamine genes in the frontal cortex and hippocampus.
Sakata K; Duke SM
Neuroscience; 2014 Feb; 260():265-75. PubMed ID: 24345476
[TBL] [Abstract][Full Text] [Related]
5. Examination of behavioral deficits triggered by targeting Bdnf in fetal or postnatal brains of mice.
Chan JP; Unger TJ; Byrnes J; Rios M
Neuroscience; 2006 Sep; 142(1):49-58. PubMed ID: 16844311
[TBL] [Abstract][Full Text] [Related]
6. A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment.
Duman CH; Schlesinger L; Kodama M; Russell DS; Duman RS
Biol Psychiatry; 2007 Mar; 61(5):661-70. PubMed ID: 16945347
[TBL] [Abstract][Full Text] [Related]
7. Social deprivation stress is a triggering factor for the emergence of anxiety- and depression-like behaviours and leads to reduced brain BDNF levels in C57BL/6J mice.
Berry A; Bellisario V; Capoccia S; Tirassa P; Calza A; Alleva E; Cirulli F
Psychoneuroendocrinology; 2012 Jun; 37(6):762-72. PubMed ID: 21974975
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic regulation of BDNF in the learned helplessness-induced animal model of depression.
Su CL; Su CW; Hsiao YH; Gean PW
J Psychiatr Res; 2016 May; 76():101-10. PubMed ID: 26921875
[TBL] [Abstract][Full Text] [Related]
9. Mice with reduced brain-derived neurotrophic factor expression show decreased choline acetyltransferase activity, but regular brain monoamine levels and unaltered emotional behavior.
Chourbaji S; Hellweg R; Brandis D; Zörner B; Zacher C; Lang UE; Henn FA; Hörtnagl H; Gass P
Brain Res Mol Brain Res; 2004 Feb; 121(1-2):28-36. PubMed ID: 14969734
[TBL] [Abstract][Full Text] [Related]
10. Antidepressive and BDNF effects of enriched environment treatment across ages in mice lacking BDNF expression through promoter IV.
Jha S; Dong BE; Xue Y; Delotterie DF; Vail MG; Sakata K
Transl Psychiatry; 2016 Sep; 6(9):e896. PubMed ID: 27648918
[TBL] [Abstract][Full Text] [Related]
11. Behavioral profile of P2X7 receptor knockout mice in animal models of depression and anxiety: relevance for neuropsychiatric disorders.
Basso AM; Bratcher NA; Harris RR; Jarvis MF; Decker MW; Rueter LE
Behav Brain Res; 2009 Mar; 198(1):83-90. PubMed ID: 18996151
[TBL] [Abstract][Full Text] [Related]
12. Loss of brain-derived neurotrophic factor gene allele exacerbates brain monoamine deficiencies and increases stress abnormalities of serotonin transporter knockout mice.
Ren-Patterson RF; Cochran LW; Holmes A; Sherrill S; Huang SJ; Tolliver T; Lesch KP; Lu B; Murphy DL
J Neurosci Res; 2005 Mar; 79(6):756-71. PubMed ID: 15672416
[TBL] [Abstract][Full Text] [Related]
13. Potential antidepressant properties of cysteamine on hippocampal BDNF levels and behavioral despair in mice.
Shieh CH; Hong CJ; Huang YH; Tsai SJ
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1590-4. PubMed ID: 18582526
[TBL] [Abstract][Full Text] [Related]
14. Antidepressant-like effect of brain-derived neurotrophic factor (BDNF).
Siuciak JA; Lewis DR; Wiegand SJ; Lindsay RM
Pharmacol Biochem Behav; 1997 Jan; 56(1):131-7. PubMed ID: 8981620
[TBL] [Abstract][Full Text] [Related]
15. Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors.
Monteggia LM; Luikart B; Barrot M; Theobold D; Malkovska I; Nef S; Parada LF; Nestler EJ
Biol Psychiatry; 2007 Jan; 61(2):187-97. PubMed ID: 16697351
[TBL] [Abstract][Full Text] [Related]
16. Deficit in BDNF does not increase vulnerability to stress but dampens antidepressant-like effects in the unpredictable chronic mild stress.
Ibarguen-Vargas Y; Surget A; Vourc'h P; Leman S; Andres CR; Gardier AM; Belzung C
Behav Brain Res; 2009 Sep; 202(2):245-51. PubMed ID: 19463708
[TBL] [Abstract][Full Text] [Related]
17. Voluntary exercise induces anxiety-like behavior in adult C57BL/6J mice correlating with hippocampal neurogenesis.
Fuss J; Ben Abdallah NM; Vogt MA; Touma C; Pacifici PG; Palme R; Witzemann V; Hellweg R; Gass P
Hippocampus; 2010 Mar; 20(3):364-76. PubMed ID: 19452518
[TBL] [Abstract][Full Text] [Related]
18. Hemokinin-1 mediates anxiolytic and anti-depressant-like actions in mice.
Borbély É; Hajna Z; Nabi L; Scheich B; Tékus V; László K; Ollmann T; Kormos V; Gaszner B; Karádi Z; Lénárd L; Paige CJ; Quinn JP; Szolcsányi J; Pintér E; Keeble J; Berger A; Helyes Z
Brain Behav Immun; 2017 Jan; 59():219-232. PubMed ID: 27621226
[TBL] [Abstract][Full Text] [Related]
19. Early social enrichment augments adult hippocampal BDNF levels and survival of BrdU-positive cells while increasing anxiety- and "depression"-like behavior.
Branchi I; D'Andrea I; Sietzema J; Fiore M; Di Fausto V; Aloe L; Alleva E
J Neurosci Res; 2006 May; 83(6):965-73. PubMed ID: 16477619
[TBL] [Abstract][Full Text] [Related]
20. Reduced anxiety and depression-like behavior in synaptotagmin IV (-/-) mice.
Ferguson GD; Herschman HR; Storm DR
Neuropharmacology; 2004 Sep; 47(4):604-11. PubMed ID: 15380377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]